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In the title compound, C21H21FN2O3, the piperidine ring is in a
chair conformation with the substituted benzisoxazole ring
system in an equatorial position. An intermolecular C—
H  O interaction is present in the crystal structure.
Comment
The chemistry of substituted 1,2-benzisoxazole amides plays
an extremely important role in the field of pharmaceuticals
and medicine (Dollery et al., 1999). The title compound, (I),
was found to be a significant in vitro antimicrobial agent when
compared to nystatin, which we have reported earlier (Priya et
al., 2005). Encouraged by this information, we now report the
crystal structure of the title compound, (I) (Fig. 1).
The piperidine ring (N1/C2–C6) adopts a chair conforma-
tion. The planar benzisoxazole ring system is in an equatorial
position [N26—C18—C4—C3 = 97.3 (2)] with respect to the
piperidine ring. A similar conformation was observed in the
related 6-fluoro-3-(4-piperidinio)benz[d]isoxazole chloride
(Yathirajan et al., 2005). The carbonyl group bisects the plane
of the piperidine ring with an angle of 56.91 (15). The
C7 O8 carbonyl group is almost coplanar with the N1—C2
bond of the piperidine ring [O8—C7—N1—C2 = 3.7 (3)] but
Figure 1
The molecular structure of (I), with displacement ellipsoids drawn at the
50% probability level. H atoms are represented as small spheres of
arbitrary radius.
it is twisted [C14—C9—C7—O8 = 62.3 (3)] from the mean
plane of the ethoxyphenyl ring. The ethoxy group is oriented
in an anti-periplanar conformation and lies in the plane of the
benzene ring [C10—O15—C16—C17 = 179.4 (2)]. The
dihedral angle between the mean plane of the piperidine ring
(N1/C2–C6) and the benzisoxazole group is 56.8 (2), while
the ethoxyphenyl ring makes a dihedral angle of 43.9 (2) with
the piperidine ring.
In the crystal structure, an inversion-generated inter-
molecular C—H  O interaction occurs (Table 1), leading to
dimeric associations of molecules, stacked in pairs when
viewed down the a axis (Fig. 3).
Experimental
The title compound was synthesized according to the published
procedure (Priya et al., 2005). Colorless single crystals of (I) were
obtained by slow evaporation of an ethyl acetate solution.
Crystal data
C21H21FN2O3
Mr = 368.40
Triclinic, P1
a = 7.029 (6) A˚
b = 9.851 (7) A˚
c = 14.120 (2) A˚
 = 107.125 (5)
 = 94.622 (5)
 = 100.513 (5)
V = 909.2 (10) A˚3
Z = 2
Dx = 1.346 Mg m
3
Mo K radiation
 = 0.10 mm1
T = 295 (2) K
Block, colorless
0.25  0.25  0.20 mm
Data collection
MacScience DIPLabo 32001
diffractometer
! scans
Absorption correction: none
4897 measured reflections
2954 independent reflections
2535 reflections with I > 2(I)
Rint = 0.030
max = 25.0

Refinement
Refinement on F 2
R[F 2 > 2(F 2)] = 0.046
wR(F 2) = 0.142
S = 1.15
2954 reflections
245 parameters
H-atom parameters constrained
w = 1/[2(Fo
2) + (0.052P)2
+ 0.3865P]
where P = (Fo
2 + 2Fc
2)/3
(/)max < 0.001
max = 0.17 e A˚
3
min = 0.19 e A˚3
Table 1
Hydrogen-bond geometry (A˚, ).
D—H  A D—H H  A D  A D—H  A
C2—H2A  O8i 0.97 2.49 3.359 (3) 149
Symmetry code: (i) xþ 1;yþ 1;z.
H atoms were placed at idealized positions (C—H = 0.92–0.98 A˚)
and refined as riding, with Uiso(H) = 1.2Ueq(C) or 1.5Ueq(methyl C).
Data collection: XPRESS (MacScience, 2002); cell refinement:
SCALEPACK (Otwinowski & Minor, 1997); data reduction:
SCALEPACK and DENZO (Otwinowski & Minor, 1997);
program(s) used to solve structure: SHELXS97 (Sheldrick, 1997);
program(s) used to refine structure: SHELXL97 (Sheldrick, 1997);
molecular graphics: PLATON (Spek, 2003) and ORTEPII (Johnson,
1976); software used to prepare material for publication: PLATON.
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Figure 2
The crystal packing in (I), viewed down the a axis. The dashed lines
indicate intermolecular C—H  O interactions.
